Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.
Accurate diagnosis of cervical lymph node metastasis is challenging, even with the latest computed tomography or MR equipment and technique. The lack of definitive criteria for distinguishing metastatic from benign nodes is a serious shortcoming of current imaging options. Dextran-coated, ultrasmall superparamagnetic iron oxide is a new MR contrast agent, which accumulates in the reticuloendothelial system of lymph nodes. Small iron oxide particles are taken up by macrophages within normal functioning nodes, reducing their signal on postcontrast MR because of the magnetic susceptibility effects of iron oxide. Metastatic nodes, on the other hand, remain high in signal on postcontrast T2*-weighted gradient echo images. Early clinical experience in cancer patients suggests that iron oxide-enhanced MR lymphography is a valuable imaging technique that may improve diagnostic accuracy for nodal metastases. This article reviews development of superparamagnetic iron oxide compounds, their imaging characteristics, and clinical experience for evaluating head and neck cancer metastases.
Anzai
Y
Y
Department of Radiology, University of Michigan Medical Center, Ann Arbor 48109-0030, USA.
Prince
M R
MR
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000556:secondary*; D003287:Contrast Media; D003937:Diagnosis, Differential; D005290:Ferric Compounds / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000175:diagnosis*; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008207:Lymphatic Metastasis; D008220:Lymphography / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D003287:Contrast Media; D005290:Ferric Compounds; C000499:ferric oxide